clindamycin hydrochloride

Generic: clindamycin hydrochloride

Labeler: mylan pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name clindamycin hydrochloride
Generic Name clindamycin hydrochloride
Labeler mylan pharmaceuticals inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

clindamycin hydrochloride 150 mg/1

Manufacturer
Mylan Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 59762-3328
Product ID 59762-3328_38c3316b-0305-40ec-af69-fe6d146fad11
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA050162
Marketing Start 1970-05-22
Marketing End 2026-08-31

Pharmacologic Class

Classes
decreased sebaceous gland activity [pe] lincosamide antibacterial [epc] lincosamides [cs] neuromuscular blockade [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 597623328
Hyphenated Format 59762-3328

Supplemental Identifiers

RxCUI
197518 284215
UPC
0359762501028 0359762332813 0359762501011
UNII
T20OQ1YN1W

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name clindamycin hydrochloride (source: ndc)
Generic Name clindamycin hydrochloride (source: ndc)
Application Number NDA050162 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (59762-3328-1)
source: ndc

Packages (1)

Ingredients (1)

clindamycin hydrochloride (150 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "38c3316b-0305-40ec-af69-fe6d146fad11", "openfda": {"upc": ["0359762501028", "0359762332813", "0359762501011"], "unii": ["T20OQ1YN1W"], "rxcui": ["197518", "284215"], "spl_set_id": ["24595bb3-07ea-4d5f-9bb3-2c2332a1fc62"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59762-3328-1)", "package_ndc": "59762-3328-1", "marketing_end_date": "20260831", "marketing_start_date": "19700522"}], "brand_name": "clindamycin hydrochloride", "product_id": "59762-3328_38c3316b-0305-40ec-af69-fe6d146fad11", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Sebaceous Gland Activity [PE]", "Lincosamide Antibacterial [EPC]", "Lincosamides [CS]", "Neuromuscular Blockade [PE]"], "product_ndc": "59762-3328", "generic_name": "clindamycin hydrochloride", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "clindamycin hydrochloride", "active_ingredients": [{"name": "CLINDAMYCIN HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "NDA050162", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20260831", "marketing_start_date": "19700522"}